
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
---|---|---|---|---|---|
ENSG
Ensign Group
|
$1.2B | $1.55 | 17.69% | 27.21% | $166.00 |
BKD
Brookdale Senior Living
|
$817.6M | -$0.14 | 4.88% | -13.75% | $7.70 |
GRDN
Guardian Pharmacy Services
|
$331.3M | $0.22 | 9.84% | 23.13% | $27.33 |
LFST
LifeStance Health Group
|
$345.1M | $0.03 | 11.21% | -95.93% | $8.50 |
PACS
PACS Group
|
$1.1B | $0.47 | 16.26% | 25.31% | $30.50 |
PNTG
Pennant Group
|
$210.6M | $0.27 | 24.62% | 48.61% | $32.80 |
Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
---|---|---|---|---|---|---|---|
ENSG
Ensign Group
|
$139.85 | $166.00 | $8B | 26.44x | $0.06 | 0.18% | 1.85x |
BKD
Brookdale Senior Living
|
$7.77 | $7.70 | $1.8B | -- | $0.00 | 0% | 0.56x |
GRDN
Guardian Pharmacy Services
|
$20.78 | $27.33 | $1.3B | -- | $0.00 | 0% | 1.01x |
LFST
LifeStance Health Group
|
$4.40 | $8.50 | $1.7B | -- | $0.00 | 0% | 1.31x |
PACS
PACS Group
|
$12.35 | $30.50 | $1.9B | 20.01x | $0.00 | 0% | 0.54x |
PNTG
Pennant Group
|
$23.76 | $32.80 | $819M | 31.26x | $0.00 | 0% | 1.05x |
Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
---|---|---|---|---|
ENSG
Ensign Group
|
6.99% | 0.779 | 1.99% | 1.32x |
BKD
Brookdale Senior Living
|
96.71% | -0.881 | 294.12% | 0.54x |
GRDN
Guardian Pharmacy Services
|
-- | 0.000 | -- | 0.77x |
LFST
LifeStance Health Group
|
15.94% | 0.855 | 10.67% | 1.32x |
PACS
PACS Group
|
46.18% | 0.462 | 10.9% | 1.57x |
PNTG
Pennant Group
|
14.74% | 0.862 | 5.93% | 1.14x |
Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
---|---|---|---|---|---|---|
ENSG
Ensign Group
|
$188.1M | $101.4M | 16.28% | 17.64% | 9.26% | $29.3M |
BKD
Brookdale Senior Living
|
$223.1M | $31.4M | -5.66% | -86.4% | -0.67% | -$18.4M |
GRDN
Guardian Pharmacy Services
|
$64.3M | $13M | -56.09% | -71.46% | 4.03% | $11.7M |
LFST
LifeStance Health Group
|
$109.8M | $1.6M | -2.07% | -2.48% | 0.48% | -$10.3M |
PACS
PACS Group
|
$153.9M | $710K | -- | -- | -0.33% | -$76.7M |
PNTG
Pennant Group
|
$29.4M | $12.7M | 8.55% | 10.97% | 6% | -$23.2M |
Brookdale Senior Living has a net margin of 6.84% compared to Ensign Group's net margin of -7.98%. Ensign Group's return on equity of 17.64% beat Brookdale Senior Living's return on equity of -86.4%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
ENSG
Ensign Group
|
16.04% | $1.37 | $2.1B |
BKD
Brookdale Senior Living
|
27.41% | -$0.28 | $4.5B |
Ensign Group has a consensus price target of $166.00, signalling upside risk potential of 18.7%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.70 which suggests that it could fall by -0.9%. Given that Ensign Group has higher upside potential than Brookdale Senior Living, analysts believe Ensign Group is more attractive than Brookdale Senior Living.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
ENSG
Ensign Group
|
4 | 1 | 0 |
BKD
Brookdale Senior Living
|
2 | 1 | 0 |
Ensign Group has a beta of 1.031, which suggesting that the stock is 3.088% more volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 0.828, suggesting its less volatile than the S&P 500 by 17.157%.
Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 4.59% of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Ensign Group quarterly revenues are $1.2B, which are larger than Brookdale Senior Living quarterly revenues of $813.9M. Ensign Group's net income of $80.3M is higher than Brookdale Senior Living's net income of -$65M. Notably, Ensign Group's price-to-earnings ratio is 26.44x while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.85x versus 0.56x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
ENSG
Ensign Group
|
1.85x | 26.44x | $1.2B | $80.3M |
BKD
Brookdale Senior Living
|
0.56x | -- | $813.9M | -$65M |
Guardian Pharmacy Services has a net margin of 6.84% compared to Ensign Group's net margin of 2.87%. Ensign Group's return on equity of 17.64% beat Guardian Pharmacy Services's return on equity of -71.46%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
ENSG
Ensign Group
|
16.04% | $1.37 | $2.1B |
GRDN
Guardian Pharmacy Services
|
19.54% | $0.15 | $163.2M |
Ensign Group has a consensus price target of $166.00, signalling upside risk potential of 18.7%. On the other hand Guardian Pharmacy Services has an analysts' consensus of $27.33 which suggests that it could grow by 31.54%. Given that Guardian Pharmacy Services has higher upside potential than Ensign Group, analysts believe Guardian Pharmacy Services is more attractive than Ensign Group.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
ENSG
Ensign Group
|
4 | 1 | 0 |
GRDN
Guardian Pharmacy Services
|
2 | 0 | 0 |
Ensign Group has a beta of 1.031, which suggesting that the stock is 3.088% more volatile than S&P 500. In comparison Guardian Pharmacy Services has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. Guardian Pharmacy Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 4.59% of its earnings as a dividend. Guardian Pharmacy Services pays out -40.96% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Ensign Group quarterly revenues are $1.2B, which are larger than Guardian Pharmacy Services quarterly revenues of $329.3M. Ensign Group's net income of $80.3M is higher than Guardian Pharmacy Services's net income of $9.4M. Notably, Ensign Group's price-to-earnings ratio is 26.44x while Guardian Pharmacy Services's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.85x versus 1.01x for Guardian Pharmacy Services. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
ENSG
Ensign Group
|
1.85x | 26.44x | $1.2B | $80.3M |
GRDN
Guardian Pharmacy Services
|
1.01x | -- | $329.3M | $9.4M |
LifeStance Health Group has a net margin of 6.84% compared to Ensign Group's net margin of 0.21%. Ensign Group's return on equity of 17.64% beat LifeStance Health Group's return on equity of -2.48%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
ENSG
Ensign Group
|
16.04% | $1.37 | $2.1B |
LFST
LifeStance Health Group
|
32.97% | -- | $1.7B |
Ensign Group has a consensus price target of $166.00, signalling upside risk potential of 18.7%. On the other hand LifeStance Health Group has an analysts' consensus of $8.50 which suggests that it could grow by 93.18%. Given that LifeStance Health Group has higher upside potential than Ensign Group, analysts believe LifeStance Health Group is more attractive than Ensign Group.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
ENSG
Ensign Group
|
4 | 1 | 0 |
LFST
LifeStance Health Group
|
5 | 1 | 0 |
Ensign Group has a beta of 1.031, which suggesting that the stock is 3.088% more volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 4.59% of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Ensign Group quarterly revenues are $1.2B, which are larger than LifeStance Health Group quarterly revenues of $333M. Ensign Group's net income of $80.3M is higher than LifeStance Health Group's net income of $709K. Notably, Ensign Group's price-to-earnings ratio is 26.44x while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.85x versus 1.31x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
ENSG
Ensign Group
|
1.85x | 26.44x | $1.2B | $80.3M |
LFST
LifeStance Health Group
|
1.31x | -- | $333M | $709K |
PACS Group has a net margin of 6.84% compared to Ensign Group's net margin of -1.11%. Ensign Group's return on equity of 17.64% beat PACS Group's return on equity of --.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
ENSG
Ensign Group
|
16.04% | $1.37 | $2.1B |
PACS
PACS Group
|
15.67% | -$0.07 | $1.1B |
Ensign Group has a consensus price target of $166.00, signalling upside risk potential of 18.7%. On the other hand PACS Group has an analysts' consensus of $30.50 which suggests that it could grow by 146.96%. Given that PACS Group has higher upside potential than Ensign Group, analysts believe PACS Group is more attractive than Ensign Group.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
ENSG
Ensign Group
|
4 | 1 | 0 |
PACS
PACS Group
|
3 | 0 | 0 |
Ensign Group has a beta of 1.031, which suggesting that the stock is 3.088% more volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 4.59% of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Ensign Group quarterly revenues are $1.2B, which are larger than PACS Group quarterly revenues of $981.8M. Ensign Group's net income of $80.3M is higher than PACS Group's net income of -$10.9M. Notably, Ensign Group's price-to-earnings ratio is 26.44x while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.85x versus 0.54x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
ENSG
Ensign Group
|
1.85x | 26.44x | $1.2B | $80.3M |
PACS
PACS Group
|
0.54x | 20.01x | $981.8M | -$10.9M |
Pennant Group has a net margin of 6.84% compared to Ensign Group's net margin of 3.71%. Ensign Group's return on equity of 17.64% beat Pennant Group's return on equity of 10.97%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
ENSG
Ensign Group
|
16.04% | $1.37 | $2.1B |
PNTG
Pennant Group
|
14% | $0.22 | $375.5M |
Ensign Group has a consensus price target of $166.00, signalling upside risk potential of 18.7%. On the other hand Pennant Group has an analysts' consensus of $32.80 which suggests that it could grow by 38.05%. Given that Pennant Group has higher upside potential than Ensign Group, analysts believe Pennant Group is more attractive than Ensign Group.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
ENSG
Ensign Group
|
4 | 1 | 0 |
PNTG
Pennant Group
|
2 | 2 | 0 |
Ensign Group has a beta of 1.031, which suggesting that the stock is 3.088% more volatile than S&P 500. In comparison Pennant Group has a beta of 1.512, suggesting its more volatile than the S&P 500 by 51.208%.
Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 4.59% of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Ensign Group quarterly revenues are $1.2B, which are larger than Pennant Group quarterly revenues of $209.8M. Ensign Group's net income of $80.3M is higher than Pennant Group's net income of $7.8M. Notably, Ensign Group's price-to-earnings ratio is 26.44x while Pennant Group's PE ratio is 31.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.85x versus 1.05x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
ENSG
Ensign Group
|
1.85x | 26.44x | $1.2B | $80.3M |
PNTG
Pennant Group
|
1.05x | 31.26x | $209.8M | $7.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.